Òdual-softÓ topical PDE4 inhibitor soft drug

to treat atopic dermatitis, lack of PD in Ph. I

from metab. opt. of prev. discont. candidate

J. Med. Chem., Oct. 15, 2020

LEO Pharma, Ballerup, DK

Structure of LEO-39652

LEO 39652 (LEO Pharma “dual-soft” topical PDE4 inhibitor soft drug clinical candidate)

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: